Technologies
Could Cellectis ADR (NASDAQ: CLLS) Regain All Of Its Losses Given A -21.85% Dip From High?
During the last session, Cellectis ADR (NASDAQ:CLLS)’s traded shares were 0.33 million, with the beta value of the company hitting 3.06. At the end of
